Cargando…

SH3BGRL2, a new downregulated tumor suppressor in clear cell renal cell carcinomas

Detalles Bibliográficos
Autor principal:	Dufies, Maeva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6997511/ https://www.ncbi.nlm.nih.gov/pubmed/32014821 http://dx.doi.org/10.1016/j.ebiom.2020.102641

Ejemplares similares

SH3BGRL2 inhibits growth and metastasis in clear cell renal cell carcinoma via activating hippo/TEAD1-Twist1 pathway
por: Yin, Lei, et al.
Publicado: (2020)

Dual-faced SH3BGRL: oncogenic in mice, tumor suppressive in humans
por: Wang, H, et al.
Publicado: (2016)

SH3BGRL Suppresses Liver Tumor Progression through Enhanced ATG5-Dependent Autophagy
por: Saleh, Abdulmomen Ali Mohammed, et al.
Publicado: (2023)

SH3BGRL confers innate drug resistance in breast cancer by stabilizing HER2 activation on cell membrane
por: Li, Hui, et al.
Publicado: (2020)

SH3BGRL3 binds to myosin 1c in a calcium dependent manner and modulates migration in the MDA-MB-231 cell line
por: Di Pisa, Filippo, et al.
Publicado: (2021)

Downregulation of PDZ Domain Containing 1 (PDZK1) is a Poor Prognostic Marker for Clear Cell Renal Cell Carcinoma
por: White-Al Habeeb, Nicole M.A.
Publicado: (2017)

CMTM4 is frequently downregulated and functions as a tumour suppressor in clear cell renal cell carcinoma
por: Li, Ting, et al.
Publicado: (2015)

The two glycolytic markers GLUT1 and MCT1 correlate with tumor grade and survival in clear-cell renal cell carcinoma
por: Ambrosetti, Damien, et al.
Publicado: (2018)

Gene SH3BGRL3 regulates acute myeloid leukemia progression through circRNA_0010984 based on competitive endogenous RNA mechanism
por: Yang, Xiancong, et al.
Publicado: (2023)

Adaptor SH3BGRL drives autophagy-mediated chemoresistance through promoting PIK3C3 translation and ATG12 stability in breast cancers
por: Zhang, Shaoyang, et al.
Publicado: (2021)

Classification of Clear Cell Renal Cell Carcinoma based on Tumor Suppressor Genomic Profiling
por: Zhong, Weimin, et al.
Publicado: (2021)

KDF1, a Novel Tumor Suppressor in Clear Cell Renal Cell Carcinoma
por: Zheng, Jing-min, et al.
Publicado: (2021)

PAPP‐A functions as a tumor suppressor and is downregulated in renal cell carcinoma
por: Lu, Yanxin, et al.
Publicado: (2021)

Taking a SPOP at renal cell carcinoma – unraveling a novel pathway for Tumor progression in clear cell RCC
por: Patel, Hiren V., et al.
Publicado: (2020)

CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma
por: Liu, Jian, et al.
Publicado: (2018)

Transmembrane Transporter Sema3D Serves as a Tumor Suppressor in Localized Clear Cell Renal Cell Carcinoma
por: Xie, Ruiyang, et al.
Publicado: (2022)

MiR-765 functions as a tumour suppressor and eliminates lipids in clear cell renal cell carcinoma by downregulating PLP2
por: Xiao, Wen, et al.
Publicado: (2020)

Promoter methylation inhibits expression of tumor suppressor KIBRA in human clear cell renal cell carcinoma
por: Schelleckes, Katrin, et al.
Publicado: (2017)

RhoB Acts as a Tumor Suppressor That Inhibits Malignancy of Clear Cell Renal Cell Carcinoma
por: Chen, Weihao, et al.
Publicado: (2016)

RNF43 is a novel tumor-suppressor and prognostic indicator in clear cell renal cell carcinoma
por: ZHU, DAWEI, et al.
Publicado: (2022)

Tumor Suppressor Properties of Small C-Terminal Domain Phosphatases in Clear Cell Renal Cell Carcinoma
por: Krasnov, George S., et al.
Publicado: (2023)

Lactotransferrin Downregulation Drives the Metastatic Progression in Clear Cell Renal Cell Carcinoma
por: Chiu, I-Jen, et al.
Publicado: (2020)

Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma
por: Liu, Yan, et al.
Publicado: (2018)

Soluble forms of PD-L1 and PD-1 as prognostic and predictive markers of sunitinib efficacy in patients with metastatic clear cell renal cell carcinoma
por: Montemagno, Christopher, et al.
Publicado: (2020)

CXCL7 is a predictive marker of sunitinib efficacy in clear cell renal cell carcinomas
por: Dufies, Maeva, et al.
Publicado: (2017)

Downregulation of the tumor suppressor HSPB7, involved in the p53 pathway, in renal cell carcinoma by hypermethylation
por: LIN, JIAYING, et al.
Publicado: (2014)

Hypermethylation of the 16q23.1 Tumor Suppressor Gene ADAMTS18 in Clear Cell Renal Cell Carcinoma
por: Xu, Ben, et al.
Publicado: (2015)

Pan-cancer Analysis of NEDD4L and Its Tumor Suppressor Effects in Clear Cell Renal Cell Carcinoma
por: Dong, Huiyue, et al.
Publicado: (2021)

Downregulation of Crystallin Lambda 1 is a New Independent Prognostic Marker in Clear Cell Renal Cell Carcinoma
por: Feng, Lingsong, et al.
Publicado: (2022)

Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma
por: KLACZ, JAKUB, et al.
Publicado: (2015)

Two Single Nucleotide Polymorphisms in the Von Hippel-Lindau Tumor Suppressor Gene in Patients with Clear Cell Renal Cell Carcinoma
por: Chrabańska, Magdalena, et al.
Publicado: (2023)

Plk1, upregulated by HIF-2, mediates metastasis and drug resistance of clear cell renal cell carcinoma
por: Dufies, Maeva, et al.
Publicado: (2021)

Frequent Epigenetic Suppression of Tumor Suppressor Gene Glutathione Peroxidase 3 by Promoter Hypermethylation and Its Clinical Implication in Clear Cell Renal Cell Carcinoma
por: Liu, Qianling, et al.
Publicado: (2015)

Identification of a new aggressive axis driven by ciliogenesis and absence of VDAC1-ΔC in clear cell Renal Cell Carcinoma patients
por: Fabbri, Lucilla, et al.
Publicado: (2020)

Soluble CD146 is a predictive marker of pejorative evolution and of sunitinib efficacy in clear cell renal cell carcinoma
por: Dufies, Maeva, et al.
Publicado: (2018)

Renal cell carcinoma with non-clear cell histology or sarcomatoid differentiation: recent insight in an unmet clinical need
por: Donskov, Frede
Publicado: (2021)

PIWI-interacting RNA 57125 restrains clear cell renal cell carcinoma metastasis by downregulating CCL3 expression
por: Ding, Lifeng, et al.
Publicado: (2021)

The Tumor Immune Microenvironment in Clear Cell Renal Cell Carcinoma
por: Monjaras-Avila, Cesar U., et al.
Publicado: (2023)

Functional Studies on Primary Tubular Epithelial Cells Indicate a Tumor Suppressor Role of SETD2 in Clear Cell Renal Cell Carcinoma()
por: Li, Jun, et al.
Publicado: (2016)

Downregulation of PPA2 expression correlates with poor prognosis of kidney renal clear cell carcinoma
por: Zhu, Wenbiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6qhkptvgvo5b5knv6snoq7t7lu